Pierre Attali, MD, MSc
Chief Medical Officer, Acting
Pierre is advising ORPHELIA Pharma on its overall clinical strategy and is involved in the preparation of the clinical protocols. He is a hepatologist with a long-lasting commitment to clinical development. He was involved in the development of multiple products during his career at Synthelabo (now Sanofi) as well as at several biotech companies (Urogene, Bioalliance Pharma/Onxeo, Sensorion, Selexel).
Emmanuèle Gerdil
13 March 2018
